Literature DB >> 22618128

Diagnosing and monitoring diabetic macular edema: structural and functional tests.

Edoardo Midena1, Stela Vujosevic.   

Abstract

Diabetic macular edema remains a major cause of visual impairment in adults despite the use of intensive glycemic control, photocoagulation therapy and new intravitreal drugs in the treatment of this disease. Although early diagnosis and treatment lead to better results, we still have patients who become legally blind. Therefore, better structural and functional characterization of this disease is necessary in order to customize treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22618128     DOI: 10.1007/s10792-012-9566-9

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  34 in total

1.  Retinal thickness and volume measurements in diabetic macular edema: a comparison of four optical coherence tomography systems.

Authors:  Jan Lammer; Christoph Scholda; Christian Prünte; Thomas Benesch; Ursula Schmidt-Erfurth; Matthias Bolz
Journal:  Retina       Date:  2011-01       Impact factor: 4.256

2.  Fixation stability and macular light sensitivity in patients with diabetic maculopathy: a microperimetric study with a scanning laser ophthalmoscope.

Authors:  Thomas Kube; Stephanie Schmidt; Frank Toonen; Bernd Kirchhof; Sebastian Wolf
Journal:  Ophthalmologica       Date:  2005 Jan-Feb       Impact factor: 3.250

3.  Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings.

Authors:  Stela Vujosevic; Edoardo Midena; Elisabetta Pilotto; Pietro P Radin; Laura Chiesa; Fabiano Cavarzeran
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

4.  Optical coherence tomography features during the evolution of serous retinal detachment in patients with diabetic macular edema.

Authors:  David Gaucher; Clemence Sebah; Ali Erginay; Belkacem Haouchine; Ramin Tadayoni; Alain Gaudric; Pascale Massin
Journal:  Am J Ophthalmol       Date:  2007-12-11       Impact factor: 5.258

5.  Diabetic retinopathy viewed as a neurosensory disorder.

Authors:  G H Bresnick
Journal:  Arch Ophthalmol       Date:  1986-07

Review 6.  Tight junctions and the molecular basis for regulation of paracellular permeability.

Authors:  J M Anderson; C M Van Itallie
Journal:  Am J Physiol       Date:  1995-10

7.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

Authors:  David J Browning; Adam R Glassman; Lloyd Paul Aiello; Roy W Beck; David M Brown; Donald S Fong; Neil M Bressler; Ronald P Danis; James L Kinyoun; Quan Dong Nguyen; Abdhish R Bhavsar; Justin Gottlieb; Dante J Pieramici; Michael E Rauser; Rajendra S Apte; Jennifer I Lim; Päivi H Miskala
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

Review 8.  Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review.

Authors:  Gianni Virgili; Francesca Menchini; Andrea F Dimastrogiovanni; Emilio Rapizzi; Ugo Menchini; Francesco Bandello; Raffaella Gortana Chiodini
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-11       Impact factor: 4.799

9.  Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.

Authors:  Stela Vujosevic; Elisa Bottega; Margherita Casciano; Elisabetta Pilotto; Enrica Convento; Edoardo Midena
Journal:  Retina       Date:  2010-06       Impact factor: 4.256

10.  Laser photocoagulation control of diabetic macular oedema without fluorescein angiography.

Authors:  A M Abu el Asrar; P H Morse
Journal:  Br J Ophthalmol       Date:  1991-02       Impact factor: 4.638

View more
  1 in total

Review 1.  AI-based structure-function correlation in age-related macular degeneration.

Authors:  Leon von der Emde; Maximilian Pfau; Frank G Holz; Monika Fleckenstein; Karsten Kortuem; Pearse A Keane; Daniel L Rubin; Steffen Schmitz-Valckenberg
Journal:  Eye (Lond)       Date:  2021-03-25       Impact factor: 3.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.